Amgen
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Amgen (AMGN) SEC Filings
Browse all Amgen SEC filings, including Annual reports (10-K), Quarterly reports (10-Q), 8-K, proxy statements (DEF 14A), and insider filings (Form 4). Access official documents by filing date, reporting period, and form type. ...more
Amgen Reports: Annual 10-K, Quarterly 10-Q & SEC Filings
SEC Filings
Date
2026
25-NSE
Exchange-filed notice of delisting
4
Insider ownership (buying, selling) activity
424B2
Prospectus variant for specific offering structures
8-K
Material company events (earnings, M&A, or leadership changes)
FWP
Free writing prospectus related to a securities offering
424B3
Updated prospectus reflecting new or changed information
S-3ASR
Automatic shelf registration for eligible issuers
10-K
Annual financial results and management updates
4
Insider ownership (buying, selling) activity
8-K
Material company events (earnings, M&A, or leadership changes)
8-K
Material company events (earnings, M&A, or leadership changes)
2025
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
10-Q
Quarterly financial results and management updates
8-K
Material company events (earnings, M&A, or leadership changes)
SC 13G/A
Updated passive ownership disclosure
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
10-Q
Quarterly financial results and management updates
8-K
Material company events (earnings, M&A, or leadership changes)
11-K
Annual performance report of employee stock plans
11-K
Annual performance report of employee stock plans
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
Amgen (Form 25-NSE) 2026
Delisting & Termination / Exchange-filed notice of delisting
Feb 24, 2026
